From: Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
Group
Healthy subjects
PD with normal cognition
PDD patients
Numbers
9
14
Female/Male
4/5
7/7
Age (years)
38–73
38–85
60–81
MMSE (mean ± SD)
29.0 ± 1.1
28.7 ± 1.2
18.7 ± 6.3
Disease duration (years)
–
9.3 ± 6.7
10.1 ± 5.3